Skip to content

Evaluating point-of-care early infant diagnosis in Zambia and Zimbabwe

Dry blood spot test (for HIV) on an infant. PNG 2005. Photo: AusAID. DFAT photo library. Creative Commons licence.

HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells

Image from Jim Riley's Cure Workshop presentation at CROI 2020.

Older age and baseline kidney function are the key risk factors for renal dysfunction while taking HIV PrEP

Image from Hamish McManus' CROI 2020 poster.

Adherence clubs linked to 30% reduction in high viral load among postpartum South African women living with HIV

Slide from Jasantha Odayar's CROI 2020 presentation showing an adherence club.

Weight gain after starting HIV treatment may have genetic influences

Image: Monthira/Shutterstock.com

HIV-positive people with fatty liver disease are at high risk for fibrosis

Image: Africa Studio/Shutterstock.com

Child with HIV maintains viral suppression for three years off treatment

Child with HIV maintains viral suppression for three years off treatment

Diagnostic challenges with PrEP use during early HIV infection

Slide from Michael Peluso's CROI 2020 presentation.

New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin

'South Sudan: Anniversary of the World's Newest Country'. Child receiving tuberculosis medicine in South Sudan. UNDP South Sudan/Brian Sokol. Creative Commons licence. Image for illustrative purposes only.